Literature DB >> 22126923

Human ScFv that block sodium ion channel activity of tetrodotoxin.

Monrat Chulanetra1, Kunan Bangphoomi, Nitat Sookrung, Jeeraphong Thanongsaksrikul, Potjanee Srimanote, Yuwaporn Sakolvarvaree, Kiattawee Choowongkomon, Wanpen Chaicumpa.   

Abstract

Tetrodotoxin (TTX) is a heterocyclic guanidinium alkaloid (C11H17N3O8) with molecular mass of ∼320 Da. The TTX and toxic analogs block sodium ion activity of mammalian nerve cells resulting in failure to conduct nerve impulse which manifested clinically in host as variable degrees of organ paralysis. Human intoxication occurs after consuming food containing the toxins. Current treatment of the poisoning is supportive and symptomatic. There has been no specific drug or antidote for the TTX mediated malady. In this study, phage clones displaying human single chain antibody fragments (HuScFv) were selected from a human ScFv phage display library. HuScFv derived from phagemid transformed Escherichia coli clones (clones s16 and s35) bound to the TTX as tested by indirect ELISA and band shift assay. Homology modeling and molecular docking revealed that VL domain of the s16-HuScFv interacted with the hydroxyl groups of C6, C9, C10 and C11 of the TTX by means of Tyr 223, Ser226 and Tyr228, while the Asp53 and Asp55 of the VH domain of s35-HuScFv interacted with the positions 1 and 2 of the guanidinium group and the hydroxyl groups at C9 and C10 of the TTX. The s16- and s35-HuScFv neutralized the TTX bioactivity in nerve cell based- and mouse bio-assays. Moreover, the HuScFv could rescue the intoxicated mice from the TTX mediated lethality. Thus, the HuScFv derived from the transformed E. coli clones have high potential as a safe, effective and specific therapeutic remedy for TTX intoxication in humans and warrant further trials.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126923     DOI: 10.1016/j.toxicon.2011.11.012

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  4 in total

1.  Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycle.

Authors:  Ornnuthchar Poungpair; Kunan Bangphoomi; Prapaipit Chaowalit; Nunghathai Sawasdee; Nichapatr Saokaew; Kiattawee Choowongkomon; Wanpen Chaicumpa; Pa-thai Yenchitsomanus
Journal:  MAbs       Date:  2014-01-15       Impact factor: 5.857

2.  Cell penetrable human scFv specific to middle domain of matrix protein-1 protects mice from lethal influenza.

Authors:  Fonthip Dong-din-on; Thaweesak Songserm; Tippawan Pissawong; Potjanee Srimanote; Jeeraphong Thanongsaksrikul; Kanyarat Thueng-in; Pattra Moonjit; Preeda Lertwatcharasarakul; Watee Seesuay; Wanpen Chaicumpa
Journal:  Viruses       Date:  2015-01-14       Impact factor: 5.048

Review 3.  Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy.

Authors:  Tobias Unkauf; Sebastian Miethe; Viola Fühner; Thomas Schirrmann; André Frenzel; Michael Hust
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 4.  Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.

Authors:  Philipp Kuhn; Viola Fühner; Tobias Unkauf; Gustavo Marcal Schmidt Garcia Moreira; André Frenzel; Sebastian Miethe; Michael Hust
Journal:  Proteomics Clin Appl       Date:  2016-06-21       Impact factor: 3.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.